You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 136 No. 11, November 2001 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (27)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Endocrine Surgery
 •Endoscopy/ Minimally Invasive Surgery
 •Liver/ Biliary Tract/ Pancreatic Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Surgical Management of Intraductal Papillary Mucinous Tumors of the Pancreas

The Role of Routine Frozen Section of the Surgical Margin, Intraoperative Endoscopic Staged Biopsies of the Wirsung Duct, and Pancreaticogastric Anastomosis

Jean-François Gigot, MD,PhD; Pierre Deprez, MD; Christine Sempoux, MD,PhD; Charles Descamps, MD; Sylvie Metairie, MD; David Glineur, MD; Pierre Gianello, MD,PhD

Arch Surg. 2001;136:1256-1262.

Hypothesis  Resection of intraductal papillary mucinous tumors of the pancreas (IPMTP) should be tailored to longitudinal spreading into the pancreatic ductal system and the presence of malignant transformation.

Objective  To review a single institutional experience with IPMTP, focusing on the operative strategy of tailoring resection to the extent of disease.

Design  Retrospective study.

Setting  Academic tertiary referral center.

Patients  Thirteen patients with IPMTP were referred for resection during the past 10 years. Malignant growth was present in 7 patients (54%). According to the determination of tumor extent, distal pancreatic resection was performed in 3 patients, pancreatoduodenectomy was done in 9 patients, and total pancreatectomy was performed in 1 patient. The median follow-up time in this series was 46 months (range, 3-104 months).

Main Outcome Measures  Preoperative and perioperative diagnosis, final pathologic results, and long-term outcome.

Results  A correct preoperative or perioperative diagnosis of IPMTP was achieved in 9 patients (69%). Routine frozen section of the surgical margin was used in all patients, changing the operative strategy in 3 (23%) of 13 patients by extending resection or leading to total pancreatectomy in 2 patients and 1 patient, respectively. A perioperative endoscopic examination of the Wirsung duct was performed in 3 patients with a correct preoperative or perioperative diagnosis of IPMTP and a dilated pancreatic duct. This allowed the examination of the entire pancreatic ductal system and staged intraductal biopsies, changing the operative strategy in 1 of these patients. Finally, after pancreatoduodenectomy, pancreaticogastric anastomosis was constructed in 5 patients, allowing endoscopic assessment of the pancreatic stump during long-term follow-up. The 5-year actuarial survival rate was 56.8% in the whole series. All patients with benign or microinvasive malignant disease remained disease-free, whereas all patients with invasive malignant disease died of tumor recurrence.

Conclusions  Accurate determination of the extent of ductal disease and residual malignant growth, when present, is critical during surgical exploration to achieve radical resection and cure. Operative strategy should be based on routine frozen section of the surgical margin and perioperative endoscopic examination of the Wirsung duct with staged intraductal biopsies when technically feasible. The routine use of pancreaticogastric anastomosis after pancreatoduodenectomy allows easy, safe, and efficient long-term endoscopic assessment of the pancreatic stump.


From the Departments of Digestive Surgery (Drs Gigot, Metairie, Glineur, and Gianello), Gastroenterology (Drs Deprez and Descamps), and Pathology (Dr Sempoux), St-Luc University Hospital, Universite Catholique de Louvain, Brussels, Belgium



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

This Month in Archives of Surgery
Arch Surg. 2001;136(11):1229.
FULL TEXT  

Archives of Surgery Reader's Choice: Continuing Medical Education
Arch Surg. 2001;136(11):1329-1330.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Intraductal Papillary Mucinous Neoplasm of Pancreas: Multi-Detector Row CT with 2D Curved Reformations--Correlation with MRCP
Sahani et al.
Radiology 2006;238:560-569.
ABSTRACT | FULL TEXT  

Intraductal Papillary Mucinous Neoplasms of the Pancreas: CT Patterns of Recurrence and Multiobserver Performance in Detecting Recurrent Neoplasm After Surgical Resection
Christensen et al.
Am. J. Roentgenol. 2004;183:1367-1374.
ABSTRACT | FULL TEXT  

Gene Expression Profiling Identifies Genes Associated with Invasive Intraductal Papillary Mucinous Neoplasms of the Pancreas
Sato et al.
Am. J. Pathol. 2004;164:903-914.
ABSTRACT | FULL TEXT  

Preoperative Predictors of Malignancy in Pancreatic Intraductal Papillary Mucinous Neoplasms
Wiesenauer et al.
Arch Surg 2003;138:610-618.
ABSTRACT | FULL TEXT  

Intraductal Papillary-Mucinous Tumors of the Pancreas: Predictive Criteria of Malignancy According to Pathological Examination of 53 Cases
Bernard et al.
Arch Surg 2002;137:1274-1278.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.